Immunohistochemical evaluation of 100 cases of encephalic metastases and correlation with primary site of the tumor;Avaliação imuno-histoquímica de 100 casos de metastases encefálicas e correlação com o sítio primário do tumor

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 47, Issue 1, 2011, Pages 57-64

  Cambruzzi, Eduardo ^a,d   Pêgas, Karla Lais ^b   Ferrari, Márcio Balbinotti ^c  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b Santa Casa de Porto Alegre ^*  (Brazil)

^c Acadêico de Medicina Pela ULBRA   (Brazil)

^d HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

Author keywords

Brain neoplasms; Central nervous system neoplasms; Immunohistochemistry; Neoplastic metastasis; Pathology

Indexed keywords

EID: 79953081893     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442011000100008     Document Type: Article

References (25)

1. AGUIAR, P. H. et al. Unusual brain metastases from papillary thyroid carcinoma: case report. Neurosurgery, v. 49, p. 1008-13, 2001. (Pubitemid 32927977)
2. BARNHOLTZ-SLOAN, J. S. et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol, v. 22, p. 2865-72, 2004. (Pubitemid 41079905)
3. BECHER, M. W. et al. Immunohistochemical analysis of metastatic neoplasms of the central nervous system. J Neuropathol Exp Neurol, v. 65, p. 935-44, 2006. (Pubitemid 44521794)
4. BINDAL, R. K. et al. Surgical treatment of multiple brain metastases. J Neurosurg, v. 79, p. 210-6, 1993. (Pubitemid 23215837)
5. CARRIER, D. A. et al. Metastatic adenocarcinoma to the brain: MR with pathologic correlation. AJNR, v. 15, p. 155-9. 1994. (Pubitemid 24033507)
6. CAVENEE, W. K. et al. World Health Organization Classification of Tumors, Tumors of the Nervous System. Pathology & Genetics, Lyon, IARC, 2007.
7. DENNIS, J. L. et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res, v. 11, p. 3766- 72, 2005. (Pubitemid 40685594)
8. DEYOUNG, B. R. et al. Immunohistological evaluation of metastatic carcinomas of unknown origin: An algorithmic approach. Semin Diagn Pathol, v. 17, p. 184-93, 2000.
9. DRLICEK, M. et al. Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary. Pathol Res Pract, v. 10, p. 727-4, 2004.
10. GASPAR, L. et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys, v. 37, p. 745-51, 1997. (Pubitemid 27181303)
11. GOTTSCHALK, J. et al. The use of immunomorphology to differentiate choroids plexus tumors from metastatic carcinomas. Cancer, v. 72, p. 1343-9, 1993. (Pubitemid 23225007)
12. GRAVILOVIC, I. T. et al. Brain metastases. J Neurooncol, v. 75, p. 5-14, 2005.
13. KHUNTIA, D. et al. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol, v. 24, p. 1295-304, 2006. (Pubitemid 46622033)
14. MCKENNEY, J. K. et al. Distinguishing metastatic small cell carcinoma (SCC) from a primary cerebellar meduloblastoma (MB) in an adult: an immunohistochemical study of thyroid transcription factor, cytokeratin AE1/3 (AE1/3) and epithelial membrane antigen. J Neuropathol Exp Neurol, v. 59, p. 420, 2000.
15. NEVES, S. et al. Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. Clin Neuropathol, v. 20, p. 38-42, 2001. (Pubitemid 32113023)
16. OLIVEIRA, A. M. et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from welldifferentiated neuroendocrine tumors of other sites. Am J Surg Pathol, v. 25, p. 815-9, 2001. (Pubitemid 32496873)
17. PERRY, A. et al. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol, v. 28, p. 938-43, 1997. (Pubitemid 27355554)
18. ROSER, F. et al. Single cerebral metastasis 3 and 19 years after primary renal cell carcinoma: case report and review of the literature. J Neurol Neurosurg Psychiatry, v. 72, p. 257-68, 2002.
19. SHEFFIELD, M. V. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol, v. 118, n. 6, p. 930-6, 2002.
20. SCHEITHAUER, B. W. et al. Tumors of the Nervous System. Armed Forces Institute of Pathology, vol. 7, series 4, Washington, 2007.
21. TAILIBERT, S. et al. Leptomeningeal metastases from solid malignancy: a review. J Neurooncol, v. 75, p. 85-99, 2005.
22. TIMÁR, J. et al. Molecular pathology of tumor metastasis. Pathol Oncol Research, v. 7, n. 3, p. 217-30, 2001.
23. TRILLET, V. et al. Cerebral metastases as first symptom of bronchogenic carcinoma. A prospective study of 37 cases. Cancer, v. 67, p. 2935-40, 1991.
24. VARADHACHARY, G. R. et al. Diagnostic strategies for unknown primary cancer. Cancer, v. 100, p. 1776-85, 2004. (Pubitemid 38529553)
25. ZACEST, A. C. et al. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg, v. 96, p. 552-8, 2002. (Pubitemid 34230211)